Nordic Nanovector appoints Mark Wright as Head of Manufacturing
Oslo, Norway, 2 January 2019 Nordic Nanovector ASA (OSE: NANO) announces the appointment of Dr Mark Wright as Head of Manufacturing. He joins the company today and will lead all aspects of the manufacture of Betalutin® for clinical trials and future commercialisation, as well as the production of new CD37-targeting candidates emerging from the company’s pipeline. Dr Wright joins from Piramal Healthcare, an international Contract Development and Manufacturing Organisation (CDMO) specialising in the production and manufacture of pharmaceutical products. Dr Wright spent the past 12 years